Compare Novartis AG (NVS) vs WD 40 Company (WDFC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novartis AG vs WD 40 Company — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while WD 40 Company trades at $237.72 (market cap $3.22B). The key difference: Novartis AG is far larger — about 90.1× WD 40 Company's market cap, and Novartis AG pays the higher dividend (3.17%). Which is the better fit depends on your goals.
| NVS | WDFC | |
|---|---|---|
Market Cap | $290.25B | $3.22B |
Sector | Health | Technology |
52-Week High | $168.62 | $264.91 |
52-Week Low | $113.50 | $187.52 |
Enterprise Value | $330.27B | $3.27B |
Dividend Yield | 3.17% | 1.7% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →About WD 40 Company
WD-40 Company is a global marketing organization dedicated to creating 'positive lasting memories' by developing and selling products that solve maintenance and cleaning problems. Built around the legendary WD-40 Multi-Use Product, the company operates an asset-light business model, focusing on brand management and innovation while utilizing a network of contract manufacturers to deliver solutions across the Americas, EIMEA, and Asia-Pacific.
Read more on WDFC →
